Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Stellar Biotechnologies Inc. (SBOT)

1.16   0 (0%) 02-22 16:00
Open: 1.17 Pre. Close: 1.16
High: 1.2042 Low: 1.1288
Volume: 40,766 Market Cap: 6M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.201 - 1.208 1.208 - 1.214
Low: 1.115 - 1.122 1.122 - 1.128
Close: 1.149 - 1.161 1.161 - 1.172

Technical analysis

as of: 2019-02-22 4:46:53 PM
Overall:       
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.44     One year: 1.64
Support: Support1: 0.96    Support2: 0.80
Resistance: Resistance1: 1.23    Resistance2: 1.40
Pivot: 1.15
Moving Average: MA(5): 1.15     MA(20): 1.19
MA(100): 1.13     MA(250): 2.24
MACD: MACD(12,26):     Signal(9): 0.01
Stochastic oscillator: %K(14,3): 50.12     %D(3): 43.98
RSI: RSI(14): 51.16
52-week: High: 7.63  Low: 0.75  Change(%): -79.0
Average Vol(K): 3-Month: 23587  10-Days: 5450

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SBOT has closed below upper band by 46.9%. Bollinger Bands are 18.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 21 Jun 2018 14:07:04 Z
Wall Street Sees Cautiously Lower Open as Trade Dispute Concerns Linger; Jobless Claims Drop

Thu, 21 Jun 2018 12:47:02 Z
US Futures Slip as Trade Dispute Concerns Linger; Data on Tap

Thu, 24 May 2018 17:24:18 Z
Midday Update: Stocks Roiled by US Withdrawal From US-North Korea Summit

Fri, 11 May 2018 20:31:53 Z
Health Care Sector Update for 05/11/2018: SBOT,SUPN,AKCA,GERN

Fri, 11 May 2018 17:51:37 Z
Health Care Sector Update for 05/11/2018: GERN,SBOT

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
atoplab.com
Tweet this page Share on Google+ Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 5.33
Shares Float (M) 5.26
% Held by Insiders
% Held by Institutions 3.30
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -2.130
EPS Est. Current Year -0.470
EPS Est. Next Year -0.380
EPS Est. Next Quarter -0.090
Forward EPS 1.#IO
Book Value (p.s.) 0.610
PEG Ratio
Profit Margin
Operating Margin -2084.61
Return on Assets (ttm) -60.0
Return on Equity (ttm) -64.4
Qtrly Rev. Growth 158.9
Gross Profit (p.s.) -0.015
Sales Per Share
EBITDA (p.s.) -0.251
Qtrly Earnings Growth
Operating Cash Flow (M) -4.78
Levered Free Cash Flow (M) -3.39

Stock Valuations

P/E -0.54
P/E Growth Ratio -0.02
P/BV 1.90
P/S 103046664.00
P/CF -1.29

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-05-07
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.